SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-029535
Filing Date
2012-05-15
Accepted
2012-05-15 16:11:07
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v312862_10q.htm 10-Q 544896
2 EXHIBIT 31.1 v312862_ex31-1.htm EX-31.1 7138
3 EXHIBIT 31.2 v312862_ex31-2.htm EX-31.2 7146
4 EXHIBIT 32.1 v312862_ex32-1.htm EX-32.1 3732
5 EXHIBIT 32.2 v312862_ex32-2.htm EX-32.2 4030
  Complete submission text file 0001144204-12-029535.txt   2147107

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nltx-20120331.xml EX-101.INS 236904
7 XBRL TAXONOMY EXTENSION SCHEMA nltx-20120331.xsd EX-101.SCH 17805
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nltx-20120331_cal.xml EX-101.CAL 30219
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nltx-20120331_def.xml EX-101.DEF 93758
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nltx-20120331_lab.xml EX-101.LAB 138132
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nltx-20120331_pre.xml EX-101.PRE 109993
Mailing Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402
Business Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402 650-458-2678
Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 12844751
SIC: 2834 Pharmaceutical Preparations